Summary of Product Characteristics
last updated on the eMC:
26/10/2007
|
SPC
|
Vicks Cough Lozenges with Honey
|
Go to top of the page | VICKS COUGH LOZENGES WITH HONEY | |
Go to top of the page | ACTIVE INGREDIENT | % | MG/LOZENGE | REFERENCE STANDARD | DEXTROMETHORPHAN | 0.204 | 7.33 | USP |
| |
Go to top of the page | LOZENGE FOR ORAL ADMINISTRATION. | |
Go to top of the pageGo to top of the page | COUGH SUPPRESSANT FOR THE RELIEF OF DRY, IRRITANT COUGH ASSOCIATED WITH COMMON COLD AND INFLUENZA. | |
Go to top of the page | ADULTS AND CHILDREN OVER 12;2 LOZENGES DISSOLVED IN THE MOUTH CONSECUTIVELY. REPEAT EVERY 6 HOURS AS NEEDED. NO MORE THAN 8 LOZENGES PER DAY. | |
Go to top of the page | KNOWN HYPERSENSITIVITY TO DEXTROMETHORPHAN OR TO ANY INGREDIENT OF THE LOZENGE.PATIENTS SUFFERING FROM SEVERE LIVER DISEASE.PATIENTS RECEIVING MONOAMINE OXIDASE INHIBITOR THERAPY OR WHO HAVE TAKEN A MONOAMINE OXIDASE INHIBITOR WITHIN THE LAST TWO WEEKSPATIENTS WITH A PRODUCTIVE COUGH | |
Go to top of the page | PATIENTS SUFFERING FROM ASTHMA, LIVER DISEASE OR IMPAIRED RESPIRATORY FUNCTION SHOULD CONSULT THEIR DOCTOR BEFORE TAKING THIS PRODUCT.DO NOT ADMINISTER TO CHILDREN UNDER 12 YEARS.IF SYMPTOMS PERSIST CONSULT YOUR DOCTOR..DO NOT EXCEED THE STATED DOSE.KEEP OUT OF REACH OF CHILDREN. | |
Go to top of the page | SEE SECTION 4.3 REGARDING MAOI THERAPY. | |
Go to top of the page | THERE IS NO LITERATURE EVIDENCE OF HAZARD DUE TO DEXTROMETHORPHAN BUT USE IS NOT RECOMMENDED DURING THE FIRST TRIMESTER AND DURING BREAST FEEDING. | |
Go to top of the page | PATIENTS SUFFERING FROM THE UNDESIRABLE EFFECTS OF DIZZINESS, EXCITATION OR MENTAL CONFUSION (SEE SECTION 4.8) SHOULD NOT DRIVE OR OPERATE MACHINERY. | |
Go to top of the page | REACTIONS ARE UNCOMMON, BUT MAY INCLUDE DIZZINESS, EXCITATION, MENTAL CONFUSION AND GASTROINTESTINAL DISTURBANCES. | |
Go to top of the page | SYMPTOMS MILD TO MODERATE OVERDOSAGE MAY CAUSE DIZZINESS, EXCITATION, MENTAL CONFUSION AND GASTROINTESTINAL DISTURBANCES. VERY HIGH DOSES MAY PRODUCE RESPIRATORY DEPRESSION.TREATMENT OF OVERDOSE GASTRIC LAVAGE AND GENERAL SUPPORTIVE MEASURES. | |
Go to top of the pageGo to top of the page | DEXTROMETHORPHAN IS A NON-OPIOID DEXTRO-ISOMER OF MORPHINE. THE DRUG'S COUGH SUPPRESSANT ACTION IS MEDIATED BY A CENTRAL ACTION ON THE COUGH CENTRE IN THE MEDULLA OBLONGATA OF THE BRAIN, RAISING THE THRESHOLD FOR COUGHING. | |
Go to top of the page | DEXTROMETHORPHAN BASE IS WELL ABSORBED FROM THE GASTROINTESTINAL TRACT, BUT THERE IS EXTENSIVE FIRST-PASS METABOLISM. METABOLISM OCCURS IN THE LIVER BY DEMETHYLATION, AND THE DRUG IS EXCRETED IN THE URINE AS UNCHANGED DEXTROMETHORPHAN AND DEMETHYLATED METABOLITES INCLUDING DEXTRORPHAN WHICH HAS SOME COUGH SUPPRESSANT ACTIVITY. THERE IS NO FAECAL ELIMINATION. URINARY EXCRETION IS NEGLIGIBLE. VARIATION IN CAPACITY TO METABOLISE DEXTROMETHORPHAN EXISTS BETWEEN INDIVIDUALS AND THE CLINICAL IMPLICATIONS OF THIS ARE NOT FULLY UNDERSTOOD. | |
Go to top of the pageGo to top of the pageGo to top of the page | SUCROSEGLUCOSE SYRUPLACTIC ACIDCITRIC ACID MONOHYDRATEPOTASSIUM HYDROXIDELEVOMENTHOLHONEYHONEY FLAVOUR L-134515EUCALYPTUS OILWATER | |
Go to top of the pageGo to top of the page | SHELF LIFE (UNOPENED): 3 YEARSSHELF LIFE (AFTER OPENING BLISTER PACK): AS FOR UNOPENED PRODUCT | |
Go to top of the pageGo to top of the page | POLYPROPYLENE BLISTER FOIL, WHITE IN COLOUR, WITH BACKING FOIL (PAPER/ALUMINIUM/POLYPROPYLENE BASED ADHESIVE) CONTAINING 12 LOZENGES.ORPOLYVINYLCHLORIDE/POLYVINYLIDENE CHLORIDE BLISTER FOIL, WHITE IN COLOUR, WITH BACKING FOIL (PAPER/ALUMINIUM/POLYVINYLIDENE BASED ADHESIVE) CONTAINING 12 LOZENGES. | |
Go to top of the pageGo to top of the pageGo to top of the page | PROCTER & GAMBLE (HEALTH & BEAUTY CARE) LIMITEDTHE HEIGHTSBROOKLANDSWEYBRIDGESURREYKT13 0XPUK | |
Go to top of the pageGo to top of the pageGo to top of the page
More information about this product
Link to this document from your website: http://www.medicines.org.uk/emc/medicine/20327/SPC/